Taysha Gene Therapies, Inc. (TSHA) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1251051,
    "name": "Taysha Gene Therapies, Inc.",
    "stock_name": "Taysha Gene Therapies, Inc.",
    "full_name": "Taysha Gene Therapies, Inc.",
    "name_url": "stocks-analysis/taysha-gene-therapies-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "5.06",
    "chg": 1,
    "chgp": "24.63%",
    "dir": 1,
    "prev_price": "4.06",
    "mcapval": "883.86",
    "mcap": "Small Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2320,
    "indexname": "S&P 500",
    "isin": "US8776191061",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "11.25 M",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/taysha-gene-therapies-inc-1251051-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Taysha Gene Therapies Experiences Revision in Its Stock Evaluation Amid Mixed Performance Metrics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/taysha-gene-therapies-inc-financial-trend-declines-from-negative-to-very-negative-amid-ongoing-challenges-3690288",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/TayshaGeneThera_fintrenddot_3690288.png",
        "date": "2025-11-11 16:12:35",
        "description": "Taysha Gene Therapies, Inc. reported a net profit of USD -45.25 million for the half-year, facing ongoing profitability challenges. Despite a decrease in raw material costs, the company experienced a decline in net sales and operating cash flow, alongside notable fluctuations in stock performance over the past year."
      },
      {
        "title": "Taysha Gene Therapies Hits Day Low at $3.97 Amid Price Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/taysha-gene-therapies-hits-day-low-at-397-amid-price-pressure-3671598",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/TayshaGeneThera_priceRelatedfactors_3671598.png",
        "date": "2025-11-04 18:37:38",
        "description": "Taysha Gene Therapies, Inc. has faced notable volatility, with a significant stock decline today. Despite a remarkable 191.5% return over the past year, the company has reported negative results for four consecutive quarters, raising concerns about its financial health and risk profile compared to historical valuations."
      },
      {
        "title": "Taysha Gene Therapies Hits New 52-Week High at $5.51",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/taysha-gene-therapies-hits-new-52-week-high-at-551-3626679",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/TayshaGeneThera_priceRelatedfactors_3626679.png",
        "date": "2025-10-16 18:29:39",
        "description": "Taysha Gene Therapies, Inc. has achieved a new 52-week high of USD 5.51, significantly up from its low of USD 1.05, reflecting a strong performance over the past year. The company, with a market cap of USD 884 million, operates in the competitive gene therapy sector despite ongoing losses."
      },
      {
        "title": "Taysha Gene Therapies Hits Day High with 7.2% Surge in Stock Price",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/taysha-gene-therapies-hits-day-high-with-72-surge-in-stock-price-3608187",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/TayshaGeneThera_priceRelatedfactors_3608187.png",
        "date": "2025-10-09 21:06:05",
        "description": "Taysha Gene Therapies, Inc. has seen significant gains, reaching an intraday high of USD 5.10, contrasting with a slight decline in the S&P 500. Despite impressive weekly and monthly performance, the company faces ongoing financial challenges, including negative results and cash flow issues over the past four quarters."
      },
      {
        "title": "Taysha Gene Therapies Hits Day Low of $4.40 Amid Price Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/taysha-gene-therapies-hits-day-low-of-440-amid-price-pressure-3601778",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/TayshaGeneThera_priceRelatedfactors_3601778.png",
        "date": "2025-10-07 22:33:00",
        "description": "Taysha Gene Therapies, Inc. saw its stock decline significantly today, contrasting with a slight gain in the S&P 500. Despite a remarkable 119.9% growth over the past year, the company faces ongoing financial challenges, including negative results for four consecutive quarters and a substantial operating cash flow deficit."
      },
      {
        "title": "Taysha Gene Therapies, Inc. Sees Revision in Stock Evaluation Amid Strong Market Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/taysha-gene-therapies-inc-technical-trend-upgrades-from-mildly-bullish-to-bullish-amid-strong-performance-3601366",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/TayshaGeneThera_technicaldot_3601366.png",
        "date": "2025-10-07 20:59:49",
        "description": "Taysha Gene Therapies, Inc. has recently revised its evaluation amid market fluctuations, with its stock currently priced at $4.42. Over the past year, it has seen a 52-week high of $5.40 and a low of $1.05, demonstrating notable performance compared to the S&P 500."
      },
      {
        "title": "Is Taysha Gene Therapies, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-taysha-gene-therapies-inc-technically-bullish-or-bearish-3599406",
        "imagepath": "",
        "date": "2025-10-07 12:26:16",
        "description": "As of 3 October 2025, the technical trend for Taysha Gene Therapies, Inc. has changed from mildly bullish to bullish. The weekly MACD is bullish, and the daily moving averages also indicate a bullish stance. Additionally, the Bollinger Bands show a bullish signal on the monthly timeframe. The KST is bullish on both weekly and monthly periods, while the monthly Dow Theory is mildly bullish. \n\nDespite the current bullish indicators, the stock has experienced a significant decline over the past five years, down 78.31%, contrasting sharply with the S&P 500's 100.56% gain during the same period. However, in the shorter term, Taysha has outperformed the S&P 500 with a year-to-date return of 155.49% compared to the S&P's 14.18%. Overall, the current technical stance is bullish with strong momentum indicators...."
      },
      {
        "title": "Taysha Gene Therapies Hits New 52-Week High at $5.40",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/taysha-gene-therapies-hits-new-52-week-high-at-540-3595689",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/TayshaGeneThera_priceRelatedfactors_3595689.png",
        "date": "2025-10-06 17:43:24",
        "description": "Taysha Gene Therapies, Inc. achieved a new 52-week high of USD 5.40 on October 3, 2025, reflecting a significant performance improvement from its previous low. With a market capitalization of USD 884 million, the company continues to navigate challenges in the biotechnology sector while outperforming the S&P 500."
      },
      {
        "title": "Is Taysha Gene Therapies, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-taysha-gene-therapies-inc-technically-bullish-or-bearish-3592207",
        "imagepath": "",
        "date": "2025-10-05 12:02:02",
        "description": "As of 3 October 2025, the technical trend for Taysha Gene Therapies, Inc. has changed from mildly bullish to bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish. The weekly RSI is bearish, but there is no signal on the monthly RSI. Bollinger Bands are bullish on both weekly and monthly time frames. Daily moving averages are bullish, and the weekly OBV is also bullish, indicating strong buying pressure. However, the weekly KST is mildly bearish, and both weekly and monthly Dow Theory indicators are mildly bullish.\n\nIn terms of performance, Taysha Gene Therapies has significantly outperformed the S&P 500 across multiple periods, with a year-to-date return of 175.14% compared to the S&P 500's 14.18%, and a one-year return of 135.64% versus 17.82%. Overall, the current technical stance is bullish, reflecting strong momentum despite some mixed signals in the indicators...."
      }
    ],
    "total": 18,
    "sid": "1251051",
    "stock_news_url": "https://www.marketsmojo.com/news/taysha-gene-therapies-inc-1251051"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Taysha Gene Therapies Experiences Revision in Its Stock Evaluation Amid Mixed Performance Metrics

2025-11-11 16:12:35

Taysha Gene Therapies, Inc. reported a net profit of USD -45.25 million for the half-year, facing ongoing profitability challenges. Despite a decrease in raw material costs, the company experienced a decline in net sales and operating cash flow, alongside notable fluctuations in stock performance over the past year.

Taysha Gene Therapies Hits Day Low at $3.97 Amid Price Pressure

2025-11-04 18:37:38

Taysha Gene Therapies, Inc. has faced notable volatility, with a significant stock decline today. Despite a remarkable 191.5% return over the past year, the company has reported negative results for four consecutive quarters, raising concerns about its financial health and risk profile compared to historical valuations.

Taysha Gene Therapies Hits New 52-Week High at $5.51

2025-10-16 18:29:39

Taysha Gene Therapies, Inc. has achieved a new 52-week high of USD 5.51, significantly up from its low of USD 1.05, reflecting a strong performance over the past year. The company, with a market cap of USD 884 million, operates in the competitive gene therapy sector despite ongoing losses.

Taysha Gene Therapies Hits Day High with 7.2% Surge in Stock Price

2025-10-09 21:06:05

Taysha Gene Therapies, Inc. has seen significant gains, reaching an intraday high of USD 5.10, contrasting with a slight decline in the S&P 500. Despite impressive weekly and monthly performance, the company faces ongoing financial challenges, including negative results and cash flow issues over the past four quarters.

Taysha Gene Therapies Hits Day Low of $4.40 Amid Price Pressure

2025-10-07 22:33:00

Taysha Gene Therapies, Inc. saw its stock decline significantly today, contrasting with a slight gain in the S&P 500. Despite a remarkable 119.9% growth over the past year, the company faces ongoing financial challenges, including negative results for four consecutive quarters and a substantial operating cash flow deficit.

Taysha Gene Therapies, Inc. Sees Revision in Stock Evaluation Amid Strong Market Performance

2025-10-07 20:59:49

Taysha Gene Therapies, Inc. has recently revised its evaluation amid market fluctuations, with its stock currently priced at $4.42. Over the past year, it has seen a 52-week high of $5.40 and a low of $1.05, demonstrating notable performance compared to the S&P 500.

Is Taysha Gene Therapies, Inc. technically bullish or bearish?

2025-10-07 12:26:16

As of 3 October 2025, the technical trend for Taysha Gene Therapies, Inc. has changed from mildly bullish to bullish. The weekly MACD is bullish, and the daily moving averages also indicate a bullish stance. Additionally, the Bollinger Bands show a bullish signal on the monthly timeframe. The KST is bullish on both weekly and monthly periods, while the monthly Dow Theory is mildly bullish. Despite the current bullish indicators, the stock has experienced a significant decline over the past five years, down 78.31%, contrasting sharply with the S&P 500's 100.56% gain during the same period. However, in the shorter term, Taysha has outperformed the S&P 500 with a year-to-date return of 155.49% compared to the S&P's 14.18%. Overall, the current technical stance is bullish with strong momentum indicators....

Taysha Gene Therapies Hits New 52-Week High at $5.40

2025-10-06 17:43:24

Taysha Gene Therapies, Inc. achieved a new 52-week high of USD 5.40 on October 3, 2025, reflecting a significant performance improvement from its previous low. With a market capitalization of USD 884 million, the company continues to navigate challenges in the biotechnology sector while outperforming the S&P 500.

Is Taysha Gene Therapies, Inc. technically bullish or bearish?

2025-10-05 12:02:02

As of 3 October 2025, the technical trend for Taysha Gene Therapies, Inc. has changed from mildly bullish to bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish. The weekly RSI is bearish, but there is no signal on the monthly RSI. Bollinger Bands are bullish on both weekly and monthly time frames. Daily moving averages are bullish, and the weekly OBV is also bullish, indicating strong buying pressure. However, the weekly KST is mildly bearish, and both weekly and monthly Dow Theory indicators are mildly bullish. In terms of performance, Taysha Gene Therapies has significantly outperformed the S&P 500 across multiple periods, with a year-to-date return of 175.14% compared to the S&P 500's 14.18%, and a one-year return of 135.64% versus 17.82%. Overall, the current technical stance is bullish, reflecting strong momentum despite some mixed signals in the indicators....

View All News